GALECTIN THERAPEUTICS INC's ticker is and the CUSIP is 363225952. A total of 2 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $200,000 | -47.1% | 420 | -62.9% | 0.01% | -64.7% |
| Q4 2017 | $378,000 | +425.0% | 1,131 | +235.6% | 0.03% | +580.0% |
| Q3 2017 | $72,000 | -54.4% | 337 | -47.4% | 0.01% | -50.0% |
| Q2 2017 | $158,000 | -18.1% | 641 | -23.7% | 0.01% | 0.0% |
| Q1 2017 | $193,000 | +739.1% | 840 | +257.4% | 0.01% | +900.0% |
| Q4 2016 | $23,000 | -75.3% | 235 | -71.5% | 0.00% | -66.7% |
| Q3 2016 | $93,000 | – | 825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 153,200 | $974,000 | 0.01% |
| SIMPLEX TRADING, LLC | 126 | $80,000 | 0.00% |